BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 20457135)

  • 1. Potential therapeutic implications of cancer stem cells in glioblastoma.
    Cheng L; Bao S; Rich JN
    Biochem Pharmacol; 2010 Sep; 80(5):654-65. PubMed ID: 20457135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
    Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
    Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
    Gimple RC; Bhargava S; Dixit D; Rich JN
    Genes Dev; 2019 Jun; 33(11-12):591-609. PubMed ID: 31160393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma cancer stem cells: Biomarker and therapeutic advances.
    Pointer KB; Clark PA; Zorniak M; Alrfaei BM; Kuo JS
    Neurochem Int; 2014 May; 71():1-7. PubMed ID: 24657832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
    Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated invasive potential of glioblastoma stem cells.
    Cheng L; Wu Q; Guryanova OA; Huang Z; Huang Q; Rich JN; Bao S
    Biochem Biophys Res Commun; 2011 Mar; 406(4):643-8. PubMed ID: 21371437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
    Jin J; Grigore F; Chen CC; Li M
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glioblastoma stem cells: cell surface markers.
    He J; Liu Y; Lubman DM
    Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance.
    Skjellegrind HK; Fayzullin A; Johnsen EO; Eide L; Langmoen IA; Moe MC; Vik-Mo EO
    Neurochem Res; 2016 Jul; 41(7):1545-58. PubMed ID: 26915110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies targeting glioblastoma stem cells.
    Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies.
    Ahmed AU; Auffinger B; Lesniak MS
    Expert Rev Neurother; 2013 May; 13(5):545-55. PubMed ID: 23621311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic pH with coordinated reduction of basic fibroblast growth factor maintains the glioblastoma stem cell-like phenotype in vitro.
    Haley EM; Tilson SG; Triantafillu UL; Magrath JW; Kim Y
    J Biosci Bioeng; 2017 May; 123(5):634-641. PubMed ID: 28063758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells and Chemoresistance in Glioblastoma Multiform: A Review Article.
    Safari M; Khoshnevisan A
    J Stem Cells; 2015; 10(4):271-85. PubMed ID: 27144829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.
    Wang X; Prager BC; Wu Q; Kim LJY; Gimple RC; Shi Y; Yang K; Morton AR; Zhou W; Zhu Z; Obara EAA; Miller TE; Song A; Lai S; Hubert CG; Jin X; Huang Z; Fang X; Dixit D; Tao W; Zhai K; Chen C; Dong Z; Zhang G; Dombrowski SM; Hamerlik P; Mack SC; Bao S; Rich JN
    Cell Stem Cell; 2018 Apr; 22(4):514-528.e5. PubMed ID: 29625067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.